online medical consultations for glp-1 obesity treatment Impact of Digital Engagement on Weight Loss Outcomes in Management Among Individuals Using and Dual GLP-1/GIP Receptor Agonist Therapy: Retrospective Cohort Service Evaluation Study Get a Weight Loss Prescription

Dabord rservs au traitement du diabte de type 2 (dulaglutide/Trulicity, liraglutide/Victoza, etc.), deux dentre eux sont dsormais autoriss dans la prise en charge de lobsit, et remboursables : le smaglutide (Wegovy) et le tirzpatide (Mounjaro)

Gmez-RamrezSBrilliETarantinoGGirelliDMuozM

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications used to manage type 2 diabetes mellitus and, in specific formulations, obesity

Demand for inpatient hospital services has fallen as recovery times shorten, more procedures move into outpatient clinics, and long-term patients receive care in less costly settings

Effective management involves optimising nutrition despite reduced appetite, maintaining hydration, addressing gastrointestinal symptoms, and implementing lifestyle modifications to support energy levels